We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

212 hedge funds and large institutions have $1.45B invested in Corcept Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 68 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 32

12% more funds holding

Funds holding: 190 → 212 (+22)

10% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $9.82M

3% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 68

1.33% less ownership

Funds ownership: 77.88% → 76.55% (-1.3%)

10% less capital invested

Capital invested by funds: $1.61B → $1.45B (-$159M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
212
Holders Change
+22
Holders Change %
+11.58%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
57
Increased
66
Reduced
68
Closed
32
Calls
$10.8M
Puts
$9.82M
Net Calls
+$1.02M
Net Calls Change
-$1.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$27.9M
2
NC
Nexthera Capital
New York
+$19.4M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$15.4M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.3M
5
Norges Bank
Norges Bank
Norway
+$8.82M

Top Sellers

1
Prudential Financial
Prudential Financial
New Jersey
-$23.4M
2
JIM
Jupiter Investment Management
United Kingdom
-$17.1M
3
BIM
Bogle Investment Management
Massachusetts
-$12.7M
4
TA
Teachers Advisors
New York
-$11.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$212M +$27.9M +1,505,877 +13%
Federated Hermes
2
Federated Hermes
Pennsylvania
$209M +$1.16M +62,715 +0.5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$144M -$11.5M -618,911 -7%
ISL
4
Ingalls & Snyder LLC
New York
$112M -$1.97M -106,155 -2%
CCM
5
Consonance Capital Management
New York
$85.3M -$11M -591,089 -10%
Renaissance Technologies
6
Renaissance Technologies
New York
$78.9M -$2.89M -156,000 -3%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$54.5M +$15.4M +833,721 +34%
State Street
8
State Street
Massachusetts
$51.6M +$4.89M +263,711 +9%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$25.9M +$5.68M +306,691 +24%
Invesco
10
Invesco
Georgia
$25.3M -$8.2M -442,599 -22%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$19.5M -$6.48M -349,529 -23%
Northern Trust
12
Northern Trust
Illinois
$18.4M +$99K +5,342 +0.5%
NC
13
Nexthera Capital
New York
$17.2M +$19.4M +1,045,196 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$14.4M -$1.24M -67,095 -7%
Ameriprise
15
Ameriprise
Minnesota
$14M -$29K -1,565 -0.2%
Arrowstreet Capital
16
Arrowstreet Capital
Massachusetts
$13.8M +$5.46M +294,834 +54%
Morgan Stanley
17
Morgan Stanley
New York
$12.9M +$8.14M +439,234 +128%
Russell Investments Group
18
Russell Investments Group
United Kingdom
$12.9M -$1.11M -59,934 -7%
Deutsche Bank
19
Deutsche Bank
Germany
$12.9M +$10.3M +556,505 +247%
Principal Financial Group
20
Principal Financial Group
Iowa
$12.8M +$420K +22,684 +3%
AAM
21
AMI Asset Management
California
$11.7M +$1.55M +83,918 +13%
Millennium Management
22
Millennium Management
New York
$9.89M -$10.7M -576,810 -49%
Bank of America
23
Bank of America
North Carolina
$9.87M +$8.59M +463,494 +340%
Goldman Sachs
24
Goldman Sachs
New York
$9.32M -$2.05M -110,630 -16%
Wells Fargo
25
Wells Fargo
California
$8.63M +$74.5K +4,023 +0.8%
1
2 3 4 5

CORT Hedge Fund Activity: Q1 2018 in Review

212 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2018, worth a combined $1.45B — down 9.9% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new CORT positions and 32 closed out — a net gain of 25 holders — while 66 added to existing stakes and 68 trimmed.

The largest buyer was BlackRock, adding an estimated $27.9M. The largest seller was Prudential Financial, cutting an estimated $23.4M.

  • 212 institutional investors held Corcept Therapeutics (CORT) as of Q1 2018, up from 190 in Q4 2017.
  • Funds reported $1.45B of Corcept Therapeutics stock for Q1 2018, down 9.9% quarter-over-quarter.
  • 57 funds opened new Corcept Therapeutics positions in Q1 2018 and 32 closed out, a net change of +25 holders.
  • The largest Corcept Therapeutics buyer in Q1 2018 was BlackRock, an estimated $27.9M added.
  • The largest Corcept Therapeutics seller in Q1 2018 was Prudential Financial, an estimated $23.4M sold.

Based on aggregated 13F filings for Q1 2018.